160 related articles for article (PubMed ID: 29070849)
21. Somatic mutation of the 5' noncoding region of the BCL-6 gene is associated with intraclonal diversity and clonal selection in histological transformation of follicular lymphoma.
Szereday Z; Csernus B; Nagy M; László T; Warnke RA; Matolcsy A
Am J Pathol; 2000 Mar; 156(3):1017-24. PubMed ID: 10702417
[TBL] [Abstract][Full Text] [Related]
22. Concomitant 1p36 deletion and TNFRSF14 mutations in primary cutaneous follicle center lymphoma frequently expressing high levels of EZH2 protein.
Gángó A; Bátai B; Varga M; Kapczár D; Papp G; Marschalkó M; Kuroli E; Schneider T; Csomor J; Matolcsy A; Bödör C; Szepesi Á
Virchows Arch; 2018 Oct; 473(4):453-462. PubMed ID: 29858685
[TBL] [Abstract][Full Text] [Related]
23. Polymerase chain reaction detection of cells carrying t(14;18) in bone marrow of patients with follicular and diffuse large B-cell lymphoma: the importance of analysis at diagnosis and significance of long-term follow-up.
Papajík T; Jedlicková K; Kriegová E; Jarosová M; Raida L; Faber E; Hubácek J; Vondráková J; Pikalová Z; Indrák K
Neoplasma; 2001; 48(6):501-5. PubMed ID: 11949845
[TBL] [Abstract][Full Text] [Related]
24. Follicular Lymphoma: The Role of the Tumor Microenvironment in Prognosis.
Sugimoto T; Watanabe T
J Clin Exp Hematop; 2016; 56(1):1-19. PubMed ID: 27334853
[TBL] [Abstract][Full Text] [Related]
25. Cell migration patterns and ongoing somatic mutations in the progression of follicular lymphoma.
Adam P; Schoof J; Hartmann M; Schwarz S; Puppe B; Ott M; Rosenwald A; Ott G; Muller-Hermelink HK
Cytogenet Genome Res; 2007; 118(2-4):328-36. PubMed ID: 18000387
[TBL] [Abstract][Full Text] [Related]
26. Recent progress in follicular lymphoma in Japan and characteristics of the duodenal type.
Yoshino T; Takata K; Tanaka T; Sato Y; Tari A; Okada H
Pathol Int; 2018 Dec; 68(12):665-676. PubMed ID: 30456840
[TBL] [Abstract][Full Text] [Related]
27. In situ follicular lymphoma: pathologic characteristics and diagnostic features.
Carbone A; Gloghini A; Santoro A
Hematol Oncol; 2012 Mar; 30(1):1-7. PubMed ID: 21560142
[TBL] [Abstract][Full Text] [Related]
28. EZH2 mutations in follicular lymphoma from different ethnic groups and associated gene expression alterations.
Guo S; Chan JK; Iqbal J; McKeithan T; Fu K; Meng B; Pan Y; Cheuk W; Luo D; Wang R; Zhang W; Greiner TC; Chan WC
Clin Cancer Res; 2014 Jun; 20(12):3078-86. PubMed ID: 24634383
[TBL] [Abstract][Full Text] [Related]
29. Peripheral blood involvement in patients with follicular lymphoma: a rare disease manifestation associated with poor prognosis.
Sarkozy C; Baseggio L; Feugier P; Callet-Bauchu E; Karlin L; Seymour JF; Lebras L; Michallet AS; Offner F; Dumas O; Traverse-Glehen A; Ffrench M; Lopez-Guillermo A; Berger F; Coiffier B; Felman P; Salles G
Br J Haematol; 2014 Mar; 164(5):659-67. PubMed ID: 24274024
[TBL] [Abstract][Full Text] [Related]
30. Non-Hodgkin lymphomas: impact of rituximab on overall survival of patients with diffuse large B-cell and follicular lymphoma.
Jaime-Pérez JC; Gamboa-Alonso CM; Vázquez-Mellado de Larracoechea A; Rodríguez-Martínez M; Gutiérrez-Aguirre CH; Marfil-Rivera LJ; Gómez-Almaguer D
Arch Med Res; 2015 Aug; 46(6):454-61. PubMed ID: 26235285
[TBL] [Abstract][Full Text] [Related]
31. Similar clinical features in follicular lymphomas with and without breaks in the BCL2 locus.
Leich E; Hoster E; Wartenberg M; Unterhalt M; Siebert R; Koch K; Klapper W; Engelhard M; Puppe B; Horn H; Staiger AM; Stuhlmann-Laeisz C; Bernd HW; Feller AC; Hummel M; Lenze D; Stein H; Hartmann S; Hansmann ML; Möller P; Hiddemann W; Dreyling M; Ott G; Rosenwald A;
Leukemia; 2016 Apr; 30(4):854-60. PubMed ID: 26621338
[TBL] [Abstract][Full Text] [Related]
32. A gene-expression profiling score for prediction of outcome in patients with follicular lymphoma: a retrospective training and validation analysis in three international cohorts.
Huet S; Tesson B; Jais JP; Feldman AL; Magnano L; Thomas E; Traverse-Glehen A; Albaud B; Carrère M; Xerri L; Ansell SM; Baseggio L; Reyes C; Tarte K; Boyault S; Haioun C; Link BK; Feugier P; Lopez-Guillermo A; Tilly H; Brice P; Hayette S; Jardin F; Offner F; Sujobert P; Gentien D; Viari A; Campo E; Cerhan JR; Salles G
Lancet Oncol; 2018 Apr; 19(4):549-561. PubMed ID: 29475724
[TBL] [Abstract][Full Text] [Related]
33. The relationship of REL proto-oncogene to pathobiology and chemoresistance in follicular and transformed follicular lymphoma.
Hu X; Baytak E; Li J; Akman B; Okay K; Hu G; Scuto A; Zhang W; Küçük C
Leuk Res; 2017 Mar; 54():30-38. PubMed ID: 28095352
[TBL] [Abstract][Full Text] [Related]
34. Hierarchy in somatic mutations arising during genomic evolution and progression of follicular lymphoma.
Green MR; Gentles AJ; Nair RV; Irish JM; Kihira S; Liu CL; Kela I; Hopmans ES; Myklebust JH; Ji H; Plevritis SK; Levy R; Alizadeh AA
Blood; 2013 Feb; 121(9):1604-11. PubMed ID: 23297126
[TBL] [Abstract][Full Text] [Related]
35. Somatic hypermutation of IGVH genes and aberrant somatic hypermutation in follicular lymphoma without BCL-2 gene rearrangement and expression.
Gagyi E; Balogh Z; Bödör C; Timár B; Reiniger L; Deák L; Csomor J; Csernus B; Szepesi A; Matolcsy A
Haematologica; 2008 Dec; 93(12):1822-8. PubMed ID: 18945749
[TBL] [Abstract][Full Text] [Related]
36. [Genetic and biological features define two types of follicular non-Hodgkin grade 3 lymphoma].
Katzenberger T; Lohr A; Ott MM; Kalla J; Rosenwald A; Müller-Hermelink HK; Ott G
Verh Dtsch Ges Pathol; 2000; 84():153-61. PubMed ID: 11217435
[TBL] [Abstract][Full Text] [Related]
37. Pediatric-type nodal follicular lymphoma: a biologically distinct lymphoma with frequent MAPK pathway mutations.
Louissaint A; Schafernak KT; Geyer JT; Kovach AE; Ghandi M; Gratzinger D; Roth CG; Paxton CN; Kim S; Namgyal C; Morin R; Morgan EA; Neuberg DS; South ST; Harris MH; Hasserjian RP; Hochberg EP; Garraway LA; Harris NL; Weinstock DM
Blood; 2016 Aug; 128(8):1093-100. PubMed ID: 27325104
[TBL] [Abstract][Full Text] [Related]
38. Clonal expansion in follicular lymphoma occurs subsequent to antigenic selection.
Zelenetz AD; Chen TT; Levy R
J Exp Med; 1992 Oct; 176(4):1137-48. PubMed ID: 1402658
[TBL] [Abstract][Full Text] [Related]
39. Prognostic implications of histologic grade and intensity of Bcl-2 expression in follicular lymphomas undergoing rituximab-containing therapy.
Maeshima AM; Taniguchi H; Nomoto J; Miyamoto K; Fukuhara S; Munakata W; Maruyama D; Kim SW; Watanabe T; Kobayashi Y; Tobinai K; Tsuda H
Hum Pathol; 2013 Nov; 44(11):2529-35. PubMed ID: 23916290
[TBL] [Abstract][Full Text] [Related]
40. The incidence of biopsy-proven transformation in follicular lymphoma in the rituximab era. A retrospective analysis from the Czech Lymphoma Study Group (CLSG) database.
Janikova A; Bortlicek Z; Campr V; Kopalova N; Benesova K; Hamouzova M; Belada D; Prochazka V; Pytlik R; Vokurka S; Pirnos J; Duras J; Mocikova H; Mayer J; Trneny M
Ann Hematol; 2018 Apr; 97(4):669-678. PubMed ID: 29318369
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
